Preparation method of levofloxacin and its intermediates
By reacting compound A and N-methylpiperazine in the presence of alkaline reagents, the one-pot method is used to simplify the operation, which solves the problems of cumbersome operation and low yield of the existing levofloxacin preparation method, and achieves high-efficiency and low-cost levofloxacin Preparation, suitable for industrial production.
Patent Information
- Application Number
- CN201910915965.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2019-09-26
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing preparation method of levofloxacin is complicated to operate, has poor yields and high costs, which are not suitable for large-scale industrial production.
In the presence of alkaline reagent, compound A reacts with N-methylpiperazine under certain temperature conditions, and compound B is prepared by post-treatment. The one-pot reaction is simplified, the yield is improved, and under the action of alkali or acid Further treatment was made to obtain levofloxacin.
It realizes the preparation method of levofloxacin, which is safe and simple to operate, short production cycle, low cost, high yield and high purity. It shortens the production cycle, reduces costs and reduces environmental pollution.
Smart Images

Figure FDA0004751455000000011 
Figure FDA0004751455000000012 
Figure FDA0004751455000000021
Abstract
Description
Technical Field
[0001] The invention relates to the field of pharmaceutical chemistry, and in particular to a preparation method of levofloxacin and an intermediate thereof. Background Art
[0002] Levofloxacin is a chiral fluoroquinolone structure, and its chemical name is: (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-[1,4]benzoxazine-6-carboxylic acid (CAS: 100986-85-4). The chemical structure of levofloxacin is shown in formula (I). Fluoroquinolones have achieved great success in clinical anti-infection treatment with their high efficiency, broad spectrum and low toxicity.
[0003]
[0004] There are many public documents on the synthesis methods of levofloxacin and its intermediates. Among them, the original research company disclosed the following synthesis route in patent US5053407:
[0005]
[0006] The synthetic route is long and requires separation of multiple intermediate compounds, which is complicated to operate and has an unsatisfactory yield of only 50%-55%, which is low. This increases the cost of preparing levofloxacin and is not suitable for large-scale industrial production.
[0007] Therefore, there is still a need to study the preparation method of levofloxacin to obtain a method with safe and simple operation, short production cycle, low cost, high yield, high purity and environmental friendliness. Summary of the invention
[0008] The object of the present invention is to solve the above problems and provide a method for preparing levofloxacin and its intermediates which is safe and simple to operate, has a short production cycle, low production cost and is suitable for industrial production.
[0009] In one aspect, the present invention provides a method for preparing a compound (B), comprising: reacting a compound (A) with N-methylpiperazine in a reaction solvent in the presence of an alkaline agent at a certain temperature, and performing post-treatment to prepare a compound (B).
[0010]
[0011] The reaction of preparing compound (B) of the present invention can be carried out in a single reaction solvent or in a mixed solvent of multiple reaction solvents. In some embodiments, the reaction solvent is selected from at least one of toluene, xylene, DMF, DMA, and DMSO. In some embodiments, the reaction solvent is toluene, which is conducive to the reaction and operation and the control of impurities.
[0012] In some embodiments, the reaction temperature of the above reaction is 20°C-150°C. In some embodiments, the reaction temperature of the above reaction is 20°C-120°C. In some embodiments, the reaction temperature of the above reaction is 20°C-80°C. In some embodiments, the reaction temperature of the above reaction is 20°C-60°C. In some embodiments, the reaction temperature of the above reaction is 20°C-40°C. In some embodiments, the reaction temperature of the above reaction is 60°C-120°C. In some embodiments, the reaction temperature of the above reaction is 80°C-120°C.
[0013] The alkaline agent is selected from at least one of triethylamine and N,N-diisopropylethylamine. In some embodiments, the alkaline agent is triethylamine.
[0014] In some embodiments, the molar ratio of the compound (A) to N-methylpiperazine is 1:1.5-1:5.0; or the molar ratio is 1:3.5-1:4.5.
[0015] In some embodiments, the molar ratio of the compound (A) to the alkaline agent is 1:2.0-1:10.
[0016] In some embodiments, the reaction time is 6h-36h; or the reaction time is 12h-24h.
[0017] In the above method, after the reaction is completed, the reaction is stopped and the obtained mixed solution containing compound (B) can be directly used in the next step, or it can be treated to separate compound (B) and then subjected to the next step of reaction.
[0018] In some embodiments, a method for preparing a levofloxacin intermediate compound (B) comprises: in a reaction solvent, in the presence of an alkaline reagent, reacting compound (A) with N-methylpiperazine at 20°C-150°C, and after the reaction is completed, post-processing to obtain compound (B).
[0019] In some embodiments, a method for preparing a levofloxacin intermediate compound (B) comprises: reacting compound (A) with N-methylpiperazine in a reaction solvent at 20°C-150°C in the presence of an alkaline reagent; after the reaction is completed, post-treatment is performed to obtain compound (B).
[0020] In some embodiments, a method for preparing a levofloxacin intermediate compound (B) comprises: in a reaction solvent, compound (A) reacts with N-methylpiperazine in the presence of an alkaline reagent at 20°C-150°C, and after the reaction is completed, a solution of compound (B) is obtained.
[0021] In some embodiments, a method for preparing a levofloxacin intermediate compound (B) comprises: reacting compound (A) with N-methylpiperazine in toluene in the presence of an alkaline reagent at 20°C-150°C; after the reaction is completed, a solution of compound (B) is obtained.
[0022] In some embodiments, a method for preparing a levofloxacin intermediate compound (B) comprises: in toluene, compound (A) and N-methylpiperazine are stirred at room temperature, and then triethylamine is added to react at 20°C-150°C. After the reaction is completed, post-treatment is performed to obtain compound (B).
[0023] In some embodiments, a method for preparing a levofloxacin intermediate compound (B) comprises: in toluene, compound (A) and N-methylpiperazine are stirred at room temperature, and then triethylamine is added, and the reaction is carried out at 20°C-150°C. After the reaction is completed, a solution of compound (B) is obtained.
[0024] In some embodiments, a method for preparing a levofloxacin intermediate compound (B) comprises: in toluene, compound (A) and N-methylpiperazine are stirred at room temperature, and then triethylamine is added, and the reaction is carried out at 20°C-150°C. After the reaction is completed, a solution of compound (B) is obtained; wherein the molar ratio of compound (A) to N-methylpiperazine is 1:1.5-1:5.0, and the molar ratio of compound (A) to triethylamine is 1:2.0-1:10.
[0025] The present invention further provides a method for preparing compound (A). A method for preparing compound (A) comprises: reacting compound 3-(N,N-dimethylamino) ethyl acrylate with 2,3,4,5-tetrafluorobenzoyl chloride at 20°C-40°C in toluene or xylene or a mixed solvent thereof in the presence of triethylamine, and after the reaction is completed, post-treating to obtain an intermediate compound (01); reacting with L-aminopropanol at pH = 5-6, and after the reaction is completed, post-treating to obtain compound (A);
[0026]
[0027] In some embodiments, a method for preparing compound (A) comprises: mixing compound 3-(N,N-dimethylamino) ethyl acrylate with triethylamine in toluene or xylene or a mixed solvent thereof, and then dropping 2,3,4,5-tetrafluorobenzoyl chloride into the system; after the dropping is completed, stirring at 20°C-40°C for 2h-6h, and performing post-treatment; obtaining an intermediate compound (01); adding acetic acid at room temperature to adjust the pH to 5-6, and then adding L-aminopropanol, keeping warm and stirring for 30min-2h, and performing post-treatment; obtaining compound (A).
[0028] In some embodiments, a method for preparing compound (B) comprises: mixing compound 3-(N,N-dimethylamino) ethyl acrylate with triethylamine in toluene or xylene, and then dropping 2,3,4,5-tetrafluorobenzoyl chloride into the system, stirring at 20°C-40°C for 2h-6h to obtain an intermediate compound (01); adding acetic acid at room temperature to adjust the pH to 5-6, and then adding L-aminopropanol, stirring for 30min-2h at this temperature, and post-treating to obtain a solution of compound (A); stirring compound (A) and N-methylpiperazine at room temperature, and then adding triethylamine, reacting at 20°C-150°C, and after the reaction is completed, obtaining a solution of compound (B); wherein the molar ratio of compound (A) to N-methylpiperazine is 1:1.5-1:5.0, and the molar ratio of compound (A) to triethylamine is 1:2.0-1:10.
[0029] In the above reaction, compound (A) reacts with N-methylpiperazine to obtain compound (B). The reaction conditions are mild and easy to operate, and the yield is nearly 100%. Compound (B) does not need to be separated and can be directly used in the next step of synthesis, which is convenient for shortening the production cycle, saving post-processing solvents, being more environmentally friendly, and suitable for industrial production.
[0030] The present invention further provides a method for preparing a compound (C). A method for preparing a compound (C), comprising: reacting a compound (B) in a reaction solvent in the presence of a base at a certain temperature, and performing post-treatment after the reaction is completed to obtain a compound (C); the reaction route is as follows:
[0031]
[0032] In some embodiments, a method for preparing compound (C) comprises: reacting compound (B) in a reaction solvent in the presence of a base under solvent reflux conditions, and performing post-treatment to obtain compound (C).
[0033] In the preparation method of compound (C), the reaction solvent can be toluene, xylene or a mixed solution thereof.
[0034] In the preparation method of compound (C), the base can be one or more of potassium carbonate, sodium carbonate, and sodium ethoxide.
[0035] In the preparation method of compound (C), the certain temperature may be 120°C-140°C.
[0036] In the preparation method of compound (C), the post-treatment includes stopping the reaction, cooling the reaction system to room temperature, adding water and stirring, filtering, adding water to the filter cake and mixing, heating to 40°C-60°C, stirring for 1h-3h, cooling to room temperature, filtering, and drying the filter cake under reduced pressure to obtain the prepared compound (C).
[0037] In some embodiments, a preparation method of compound (C) comprises: mixing compound 3-(N,N-dimethylamino) ethyl acrylate with triethylamine in toluene or xylene, and then dropping 2,3,4,5-tetrafluorobenzoyl chloride into the system, stirring at 20°C-40°C for 2h-6h to obtain an intermediate compound (01); adding acetic acid to adjust the pH to 5-6 at room temperature, and then adding L-aminopropanol, stirring at this temperature for 30min-2h, and post-treating to obtain a solution of compound (A); and then mixing compound (A) with N-methylpiperazine at room temperature. Stirring, then adding triethylamine, reacting at 20°C-120°C, after the reaction is completed, obtaining a solution of compound (B); reacting compound (B) at 120°C-140°C in the presence of a base, and after post-treatment, obtaining compound (C); wherein the molar ratio of compound (A) to N-methylpiperazine is 1:1.5-1:5.0, the molar ratio of compound (A) to triethylamine is 1:2.0-1:10; the molar ratio of compound (B) to the base is 1:2.0-1:4.0, and the base is at least one of potassium carbonate, sodium carbonate, and sodium ethoxide; the reaction route is as follows:
[0038]
[0039] In some embodiments, a method for preparing compound (C) comprises the following reaction steps:
[0040] a) ethyl 3-(N,N-dimethylamino)acrylate and triethylamine are added to toluene or xylene to dissolve, and then 2,3,4,5-tetrafluorobenzoyl chloride is added dropwise, and the mixture is stirred at 20°C-30°C to react to obtain compound (01);
[0041] b) adding acetic acid to step a until the pH is 5-6, then adding L-aminopropanol, stirring at room temperature, and post-treating the reaction solution to obtain compound (A);
[0042] c) adding N-methylpiperazine to step b, raising the temperature to 20° C.-150° C., and continuing the reaction for 12 h-36 h to obtain a solution of compound (B);
[0043] d) adding a base to step c, raising the temperature to 120° C.-140° C., reflux reaction for 2 h-8 h, and performing post-treatment to obtain compound (C), wherein the base is at least one of potassium carbonate, sodium carbonate or sodium ethoxide;
[0044] Compound (C) is further hydrolyzed under the action of an acid to obtain levofloxacin.
[0045] The intermediate and preparation method thereof provided by the present invention are as follows: the intermediate compound (01) reacts with L-aminopropanol to obtain the intermediate compound (A); the compound (A) reacts with N-methylpiperazine to obtain the compound (B); the compound (B) is cyclized under the action of a base to obtain the compound (C); the corresponding intermediate compound (01), compound (A), compound (B), and compound (C) can be separated in the whole reaction process, or any one or more of the three intermediate compounds (01), compound (A), and compound (B) can be not separated, or only the intermediate compound (C) can be separated to realize a one-pot reaction, and finally levofloxacin can be obtained by acid hydrolysis. Through technical improvement, multi-step reactions can be integrated into a one-pot reaction, the experimental operation is simplified, the production cycle is greatly shortened, the yield is increased by about 20%-25%, the cost is reduced, the multi-step post-processing process is saved, the energy consumption is low, the three wastes are reduced, the environment is friendly, and it is conducive to large-scale industrial production.
[0046] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
[0047] In the present invention, expressions such as "compound A" and "compound represented by formula A" refer to the same compound. DETAILED DESCRIPTION
[0048] In order to enable those skilled in the art to better understand the technical solution of the present invention, some non-limiting embodiments are further disclosed below to further describe the present invention in detail.
[0049] The reagents used in the present invention can be purchased from the market or prepared by the method described in the present invention.
[0050] In the present invention, DMF represents N,N-dimethylformamide, DMA represents N,N-dimethylacetamide, and DMSO represents dimethyl sulfoxide.
[0051] In the present invention, K2CO3 represents potassium carbonate.
[0052] In the present invention, room temperature refers to ambient temperature, which is generally 20°C-40°C or 20°C-30°C.
[0053] 1. Preparation of Levofloxacin
[0054] 3-(N,N-dimethylamino)ethyl acrylate (13.48 g), triethylamine (12.38 g) and toluene (180 mL) were added to the reaction bottle, stirring was started, and 2,3,4,5-tetrafluorobenzoyl chloride (20 g) was added dropwise to the system. After the addition was completed, stirring was continued at 27°C for 4 h to obtain compound (01); acetic acid was added at room temperature to adjust the pH to 5-6, and L-aminopropanol was added to the system, stirring was continued for 30 min, 40 ml of water was added, and stirring was continued for 15 min. The liquid was separated, and the lower aqueous phase was discarded. The organic phase was compound (A) solution; N-methylpiperazine (4.4 g) was added to the system, 2 The mixture was stirred at 7°C for 24 h to obtain a solution of compound (B); K2CO3 (14.3 g) was added, the temperature was raised to 140°C, the solid was refluxed for 16 h, the temperature was lowered to 25°C, 25 ml of water was added, the mixture was filtered, and the filtrate was dried under reduced pressure at 80°C to obtain compound (C); compound (C) was mixed with ethanol (60 mL), water (60 mL), and 30% HCl (140 g), the mixture was dissolved, the temperature was raised to 83°C, the mixture was kept stirred for 36 h, the temperature was lowered for crystallization, and the mixture was filtered to obtain levofloxacin: 25.5 g; the yield was 75%, the purity was 99%, and LC-MS: m / z (ESI): 362.1511 (M+H)+.
[0055] 2. Preparation of Levofloxacin
[0056] 3-(N,N-dimethylamino)ethyl acrylate (13.48 g), triethylamine (12.38 g) and toluene (180 mL) were added to the reaction bottle, stirring was started, and 2,3,4,5-tetrafluorobenzoyl chloride (20 g) was added dropwise to the system. After the addition was completed, stirring was continued at 27°C for 4 h to obtain compound (01); acetic acid was added at room temperature to adjust the pH to 5-6, and L-aminopropanol was added to the system, stirring was continued for 30 min, 40 ml of water was added, and stirring was continued for 15 min. The liquid was separated, and the lower aqueous phase was discarded. The organic phase was compound (A) solution; N-methylpiperazine (4.4 g) was added to the system, and the temperature was raised to 12 0℃, keep warm and stir for 24h to obtain a solution of compound (B); add K2CO3 (14.3g), heat to 140℃, reflux the solid to separate water for 16h, cool to 25℃, add 25ml of water, filter, and dry the filtrate at 80℃ under reduced pressure to obtain compound (C); compound (C) is mixed with ethanol (60mL), water (60mL), and 30% HCl (140g), dissolve, heat to 83℃, keep warm and stir for 36h, cool to crystallize, filter, and obtain levofloxacin: 26.5g; the yield is 77.9%, the detection: purity is 99.1%, LC-MS: m / z (ESI): 362.1511 (M+H)+.
[0057] 3. Preparation of compound (C)
[0058] Add 3-(N,N-dimethylamino)ethyl acrylate (13.48 g), triethylamine (12.38 g) and toluene (180 mL) to the reaction bottle, start stirring, and then add 2,3,4,5-tetrafluorobenzoyl chloride (20 g) dropwise to the system. After the addition is complete, continue stirring at 27°C for 4 h to obtain compound (01); add acetic acid at room temperature to adjust the pH to 5-6, then add L-aminopropanol to the system, continue stirring for 30 min, add 40 ml of water, stir for 15 min, separate the liquids, and discard the lower aqueous phase , the organic phase is the solution of compound (A); then N-methylpiperazine (4.4 g) is added to the system, the temperature is raised to 120°C, and the mixture is stirred for 24 hours to obtain a solution of compound (B); K2CO3 (14.3 g) is added, the temperature is raised to 140°C, the solid is refluxed to separate water for 16 hours, the temperature is lowered to 25°C, 25 ml of water is added, the mixture is filtered, and the filtrate is dried under reduced pressure to obtain compound (C), 30 g; the yield is 81.9%, the detection: the purity is 92%, LC-MS: m / z (ESI): 390.1823 (M+H)+.
[0059] The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein within the content, spirit and scope of the present invention to implement and apply the technology of the present invention. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention.
Claims
1. A method for preparing a compound (B), comprising reacting a compound (A) with N-methylpiperazine in a reaction solvent in the presence of an alkaline agent at a certain temperature, and then performing post-treatment to obtain a compound (B), wherein the reaction formula is as shown below: in, The alkaline reagent is selected from at least one of triethylamine and N,N-diisopropylethylamine.
2. The method according to claim 1, wherein the molar ratio of the compound (A) to N-methylpiperazine is 1:1.5-1:5.0; or the molar ratio of the compound (A) to the alkaline agent is 1:2.0-1:
10.
3. The method according to claim 1, wherein the reaction solvent is selected from at least one of toluene, xylene, DMF, DMA, and DMSO. The method according to claim 1 , wherein the reaction temperature is 20° C.-150° C.
5. The method of claim 1, wherein the post-processing comprises: The reaction was stopped and the resulting mixed solution containing compound (B) was directly used in the next step.
6. A method for preparing compound (C), comprising reacting compound (B) prepared by the method according to claim 1 at 120°C-140°C in the presence of a base, and performing post-treatment after the reaction to obtain compound (C); the reaction formula is shown below: in, The alkali is at least one of potassium carbonate, sodium carbonate and sodium ethoxide.
7. The method for preparing compound (C) according to claim 6, wherein the reaction solvent is toluene, xylene or a mixed solution thereof.
8. The method for preparing compound (C) according to claim 6, wherein the post-treatment comprises stopping the reaction, cooling the reaction system to room temperature, adding water and stirring, filtering, adding water to the filter cake and mixing, heating to 40°C-60°C, stirring for 1h-3h, cooling to room temperature, filtering, and drying to obtain compound (C).
9. The method of claim 1 or 6, further comprising: mixing the compound 3-(N,N-dimethylamino) ethyl acrylate with triethylamine in toluene or xylene, then dropping 2,3,4,5-tetrafluorobenzoyl chloride into the system, stirring at 20°C-40°C for 2h-6h, and performing post-treatment to obtain compound (01); adding acetic acid to compound (01) at room temperature to adjust the pH to 5-6, adding L-aminopropanol, and stirring at this temperature for 30min-2h, and performing post-treatment to obtain compound (A); the reaction scheme is as follows:
10. The method according to claim 9, wherein the molar ratio of the compound (A) to N-methylpiperazine is 1:1.5-1:5.0; and the molar ratio of the compound (A) to triethylamine is 1:2.0-1:10.
